Showing 1,541 - 1,560 results of 8,597 for search 'effective dysfunction', query time: 0.12s Refine Results
  1. 1541

    Construction and Clinical Relevance of a Predictive Model of Coronary Microcirculatory Dysfunction in Patients With Acute Myocardial Infarction Following Percutaneous Coronary Inte... by Shuai Wang, Yuanyuan Zhao, Yanlong Zhao, Yanling Wang, Zhenxing Fan, Zhi Liu

    Published 2025-06-01
    “…Conclusion: The predictive model developed in this study effectively identifies the risk of microcirculatory dysfunction in AMI patients after PCI, providing important insights for clinical decision-making. …”
    Get full text
    Article
  2. 1542
  3. 1543

    Morroniside ameliorates sevoflurane anesthesia-induced cognitive dysfunction in aged mice through modulating the TLR4/NF-κB pathway by Jianxing Chen, Bo Peng, Wenqian Lin, Yinjun Mao, Yongsheng Wang

    Published 2024-12-01
    “…A model of cognitive dysfunction induced by Sev was established in aged mice and tested for behavioral analysis using the water maze experiment. …”
    Get full text
    Article
  4. 1544

    Causal association of cholesterol metabolism-related proteins with hepatocellular carcinoma and dysfunction-associated steatotic liver disease: a mendelian randomization study by Dianzhe Tian, Shitao Jiang, Yaoge Liu, Han Zheng, Lei Zhang, Yiyao Xu, Xin Lu

    Published 2025-06-01
    “…Abstract Background Dysregulation of cholesterol metabolism has been recognized as a critical driver in the pathogenesis of hepatic disorders, particularly hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatotic liver disease (MASLD). …”
    Get full text
    Article
  5. 1545
  6. 1546

    Targeting the gut microbiota-bile acid axis: Therapeutic strategies for cholestatic liver disease and metabolic dysfunction-associated steatotic liver disease by Xingtao Zhao, Ruolan Li, Ruiqi Sun, Qiong Pan, Hongyan Lu, Jin Chai

    Published 2025-09-01
    “…Cholestatic liver disease (CSLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are both associated with abnormal bile acid (BA) metabolism and have a steadily increasing incidence and prevalence worldwide. …”
    Get full text
    Article
  7. 1547
  8. 1548

    Association between the dietary index for gut microbiota and all-cause/cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease by Wenhao Wu, Jiacheng Cheng, Zebin Hou, Qi Yan, Xiaojuan Wang, Junhua He, Yikun Zhu, Jin Li

    Published 2025-07-01
    “…Abstract Background Nutrient interactions with the gut microbiome modulate the development of metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiovascular disease. …”
    Get full text
    Article
  9. 1549

    FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions by Citong Zhang, Wei Wei, Minghan Chi, Yao Wan, Xue Li, Manlin Qi, Yanmin Zhou

    Published 2019-01-01
    “…Osteocyte plays an essential role in bone metabolism by regulating osteoblast and osteoclast activities. Dysfunction or apoptosis of osteocyte will severely endanger the bone homeostasis and result in bone diseases such as osteoporosis. …”
    Get full text
    Article
  10. 1550

    Kidney dysfunction and associated factors among adults living with human immuno-deficiency virus in Africa: a systematic review and meta-analysis by Worku Chekol Tassew, Agerie Mengistie Zeleke, Yeshiwas Ayale Ferede, Girum Meseret Ayenew

    Published 2025-02-01
    “…Abstract Background Kidney dysfunction among adults living with Human Immuno-Deficiency Virus (HIV) increases the risk of drug-related side effects, acute kidney injury, hospitalization, and progression to end-stage kidney disease. …”
    Get full text
    Article
  11. 1551

    Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study by Woo-Young Shin, Eun Seok Kang, Yun Hwan Oh, Meng Sha, Qiang Xia, Seogsong Jeong, Yoosun Cho

    Published 2025-04-01
    “…Abstract Background The relationship between the newly proposed steatotic liver disease (SLD) subtypes—metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic alcohol-associated liver disease (MetALD)—and dementia is understudied. …”
    Get full text
    Article
  12. 1552
  13. 1553

    Predictive factors of sexual dysfunction and quality of life among type 2 diabetes outpatients in southern Iran: a cross-sectional survey by Vahid Keshtkar, Mina Zarmehrparirouy, Mohammad Ali Izadi, Mohammad Hossein Sharifi

    Published 2025-03-01
    “…Sexual dysfunction is a long-term consequence of diabetes that is widely ignored in personal management, even though it can have an adverse effect on QOL.Design This research was designed as a cross-sectional study.Setting 12 diabetes centres and clinics in Shiraz, south of Iran.Participants 390 male patients with T2D mellitus participated in this project. …”
    Get full text
    Article
  14. 1554
  15. 1555

    Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction by Guan Qun Zhu, Seung Hwan Jeon, Woong Jin Bae, Sae Woong Choi, Hyun Cheol Jeong, Kang Sup Kim, Su Jin Kim, Hyuk Jin Cho, U. Syn Ha, Sung Hoo Hong, Ji Youl Lee, Eun Bi Kwon, Sae Woong Kim

    Published 2018-01-01
    “…Mesenchymal stem cell therapy (MSCT) and defocused low-energy shock wave therapy (ESWT) has been shown to ameliorate erectile dysfunction (ED). However, the interactions and effects of action between MSCT and ESWT remain poorly understood. …”
    Get full text
    Article
  16. 1556

    Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study by Ge Guo, Zihan Jing, Wenrui Dou, Guiqin Wang, JunJie Dang, Yajie Li, Ruqiong Wang, Huan Zhang, Jing Sun, Lihua Shang

    Published 2024-12-01
    “…IntroductionThe relationship between immune-related thyroid dysfunction (irTD) and survival rates in cancer patients remains unclear. …”
    Get full text
    Article
  17. 1557

    Severe Dietary Energy Restriction for Compensated Cirrhosis Due to Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Controlled Trial by Dimitrios A. Koutoukidis, Susan A. Jebb, Jeremy W. Tomlinson, Ferenc E. Mozes, Michael Pavlides, Miriam Lacharie, Francesca Saffioti, Paul Aveyard, Jeremy F. Cobbold

    Published 2025-06-01
    “…ABSTRACT Background Compensated cirrhosis due to metabolic dysfunction‐associated steatotic liver disease (CC‐MASLD) increases morbidity and mortality risk but has no aetiology‐specific treatment. …”
    Get full text
    Article
  18. 1558
  19. 1559

    Impact of advanced prostatic cancer treatment on quality of life and sexual function by Fernando Parma Marsicano, Andy Petroianu

    Published 2023-12-01
    “…All these adverse effects were worse when the surgical procedure was associated with radiotherapy and androgen deprivation hormone therapy. …”
    Get full text
    Article
  20. 1560